作者
Elizabeth G Raymond, Daniel Grossman, Alice Mark, Ushma D Upadhyay, Gillian Dean, Mitchell D Creinin, Leah Coplon, Jamila Perritt, Jessica M Atrio, DeShawn Taylor, Marji Gold
发表日期
2020/6/1
期刊
Contraception
卷号
101
期号
6
页码范围
361-366
出版商
Elsevier
简介
The COVID-19 pandemic is acutely threatening access to essential health services, including abortion [1]. Across all fields of medicine, changes in practice models are occurring rapidly. For patients seeking abortion, urgent modifications of current protocols are needed to ensure that patients can continue to obtain this time-sensitive treatment while limiting transmission of infection by maintaining distance between and among patients and providers. Remote delivery of care, which has recently been endorsed by local, state, and federal authorities as a key epidemic control measure [2], will be indispensable to accommodate patients and staff who are navigating quarantines, stay-at-home directives, lack of transportation, new family or work obligations, or other unavoidable circumstances that impede their ability to go in in person to a health facility.
Fortunately, medication abortion (MA) using mifepristone and …
引用总数